These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 30172422)
1. Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer. Abbas M; Ahmed A; Khan GJ; Baig MMFA; Naveed M; Mikrani R; Cao T; Naeem S; Shi M; Dingding C Curr Probl Cancer; 2019 Feb; 43(1):5-17. PubMed ID: 30172422 [TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. Sun Z; Zhang N World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664 [TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms]. Chen L; Zhang Y; Chen M; Chen J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189 [TBL] [Abstract][Full Text] [Related]
5. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer. Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496 [TBL] [Abstract][Full Text] [Related]
6. Clinical application of serum tumor abnormal protein from patients with gastric cancer. Liu J; Huang XE Asian Pac J Cancer Prev; 2015; 16(9):4041-4. PubMed ID: 25987083 [TBL] [Abstract][Full Text] [Related]
7. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872 [TBL] [Abstract][Full Text] [Related]
9. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. Kim JH; Jun KH; Jung H; Park IS; Chin HM Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088 [TBL] [Abstract][Full Text] [Related]
11. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer. Yin LK; Sun XQ; Mou DZ Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051 [TBL] [Abstract][Full Text] [Related]
12. Elevated Pretreatment CEA and CA19-9 Levels are Related to Early Treatment Failure in Esophageal Adenocarcinoma. van der Kaaij RT; Voncken FEM; van Dieren JM; Snaebjornsson P; Korse CM; Grootscholten C; Aleman BMP; van Sandick JW Am J Clin Oncol; 2019 Apr; 42(4):345-350. PubMed ID: 30724779 [TBL] [Abstract][Full Text] [Related]
13. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Lai IR; Lee WJ; Huang MT; Lin HH Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226 [TBL] [Abstract][Full Text] [Related]
14. Changing patterns of Serum CEA and CA199 for Evaluating the Response to First-line Chemotherapy in Patients with Advanced Gastric Adenocarcinoma. He B; Zhang HQ; Xiong SP; Lu S; Wan YY; Song RF Asian Pac J Cancer Prev; 2015; 16(8):3111-6. PubMed ID: 25921105 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer. Liang Y; Wang W; Fang C; Raj SS; Hu WM; Li QW; Zhou ZW Oncotarget; 2016 Aug; 7(31):49565-49573. PubMed ID: 27385101 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination. Emoto S; Ishigami H; Yamashita H; Yamaguchi H; Kaisaki S; Kitayama J Gastric Cancer; 2012 Apr; 15(2):154-61. PubMed ID: 21892754 [TBL] [Abstract][Full Text] [Related]
17. Clinical Evaluation of Serum Tumor Markers in the Diagnosis of Gastric Adenocarcinoma Staging and Grading. Ghaderi B; Moghbel H; Daneshkhah N; Babahajian A; Sheikhesmaeili F J Gastrointest Cancer; 2019 Sep; 50(3):525-529. PubMed ID: 29806060 [TBL] [Abstract][Full Text] [Related]
18. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer. Yang XQ; Chen C; Wang FB; Peng CW; Li Y Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902 [TBL] [Abstract][Full Text] [Related]
20. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer. Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]